Please use a PC Browser to access Register-Tadawul
Forecasting The Future: 13 Analyst Projections For Nasdaq
Nasdaq, Inc. NDAQ | 88.64 | +0.42% |
Analysts' ratings for Nasdaq (NASDAQ:NDAQ) over the last quarter vary from bullish to bearish, as provided by 13 analysts.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 9 | 2 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 4 | 1 | 0 | 0 |
| 2M Ago | 1 | 3 | 1 | 0 | 0 |
| 3M Ago | 0 | 2 | 0 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $110.85, a high estimate of $120.00, and a low estimate of $101.00. Marking an increase of 2.2%, the current average surpasses the previous average price target of $108.46.

Diving into Analyst Ratings: An In-Depth Exploration
The analysis of recent analyst actions sheds light on the perception of Nasdaq by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Bill Katz | TD Cowen | Raises | Buy | $106.00 | $105.00 |
| Michael Cho | JP Morgan | Raises | Overweight | $101.00 | $100.00 |
| Bill Katz | TD Cowen | Raises | Hold | $105.00 | $104.00 |
| Michael Cyprys | Morgan Stanley | Raises | Overweight | $116.00 | $113.00 |
| Ashish Sabadra | RBC Capital | Maintains | Outperform | $108.00 | $108.00 |
| Benjamin Budish | Barclays | Raises | Overweight | $115.00 | $114.00 |
| Michael Cyprys | Morgan Stanley | Raises | Overweight | $113.00 | $111.00 |
| Bill Katz | TD Cowen | Raises | Hold | $104.00 | $96.00 |
| Alex Kramm | UBS | Raises | Buy | $120.00 | $115.00 |
| Michael Cho | JP Morgan | Raises | Overweight | $113.00 | $111.00 |
| Benjamin Budish | Barclays | Raises | Overweight | $115.00 | $114.00 |
| Michael Cyprys | Morgan Stanley | Raises | Overweight | $111.00 | $110.00 |
| Benjamin Budish | Barclays | Raises | Overweight | $114.00 | $109.00 |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Nasdaq. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Nasdaq compared to the broader market.
- Price Targets: Analysts predict movements in price targets, offering estimates for Nasdaq's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Nasdaq's market standing. Stay informed and make data-driven decisions with our Ratings Table.
Stay up to date on Nasdaq analyst ratings.
Discovering Nasdaq: A Closer Look
Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its trading business (about 22.5% of sales), the company sells market and financial data to investors, offers Nasdaq-branded indexes, and lists companies through its capital access segment (42.5%). Nasdaq's newest segment, financial technology, was primarily constructed through the acquisitions of Verafin and Adenza and has expanded the company into capital management, financial crime, and regulatory compliance software (35%) as it seeks to become a diversified technology company.
Key Indicators: Nasdaq's Financial Health
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: Nasdaq's revenue growth over a period of 3M has been noteworthy. As of 31 December, 2025, the company achieved a revenue growth rate of approximately 4.63%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: Nasdaq's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 24.39%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Nasdaq's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 4.27%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.68%, the company showcases effective utilization of assets.
Debt Management: Nasdaq's debt-to-equity ratio stands notably higher than the industry average, reaching 0.77. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
The Core of Analyst Ratings: What Every Investor Should Know
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.


